Publication details

Past and present phage therapy research and practice in the Czech Republic – contribution to phage therapy in Europe

Investor logo
Authors

PANTŮČEK Roman DOŠKAŘ Jiří BOŠTÍK Josef KOCOURKOVÁ Dana PETRZIK Karel KOPTÍKOVÁ Jana BENEŠÍK Martin PLEVKA Pavel FÜZIK Tibor MAŠLAŇOVÁ Ivana BOTKA Tibor NEPEŘENÝ Jiří ZELLER Daniel KUNTOVÁ Lucie SNOPKOVÁ Kateřina HRALA Matěj MOŠA Marek

Year of publication 2026
Type Peer-reviewed scientific article
Magazine / Source Virology Journal
MU Faculty or unit

Faculty of Science

Citation
web https://link.springer.com/article/10.1186/s12985-026-03296-x
Doi https://doi.org/10.1186/s12985-026-03296-x
Keywords Phage therapy; Bacteriophage; Non-traditional antibacterial therapies; Stafal; Biocontrol; Enzybiotics; Staphylococcal infections; Osteomyelitis; Kayvirus; Plant pathogenic bacteria
Attached files
Description Renewed interest in bacteriophage therapy, driven by the global rise of antimicrobial resistance, is accelerating efforts to establish its rational, evidence-based use in clinical practice. This review provides a comprehensive overview of the historical milestones, current status, and potential of phage applications in the Czech Republic. We show that the country has built on a long tradition of phage therapy, integrating academic research, industrial capabilities, and clinical practice. Since 2000, more than 30 competitively funded projects have addressed key challenges in phage safety, genomic characterization, formulation, delivery, phage-antibiotic synergy, and GMP-compliant manufacturing. Clinical translation is advancing through named-patient basis treatments and the ongoing trials. Beyond human medicine, phage applications have also been explored in veterinary medicine, food safety, and agriculture. Overall, the evidence reviewed indicates that the country has established substantial expertise and infrastructure for phage research and implementation, positioning it as an important European contributor to the development of phage therapy. In a concluding discussion, this review identifies key priorities for sustainable access to phage preparations and the broader integration of phage-based interventions into healthcare systems within the rapidly evolving European regulatory framework.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info